Downloads

1. Robust, Flexible Cell Lines That Fit Your Strategy 9/16/2025

   We bring over two decades of cell line development (CLD) experience together with state-of-the-art technologies to ensure every step is strategically designed and meticulously executed.

2. Pharmaceutical Cleanroom Components 9/16/2025

   The AES modular cleanroom system is engineered with inherent flexibility to seamlessly incorporate essential modular cleanroom accessories while maintaining structural integrity and eliminating the need for costly engineering rework.

3. Cleanrooms For R&D And Testing Facilities 9/16/2025

   Research and development is the heart of life sciences innovation, which is why AES provides modular cleanroom solutions that let teams iterate freely and scale as needed.

4. Modular Biopharma Cleanrooms 9/16/2025

   AES has transformed the landscape of modular cleanroom design, manufacturing and construction. What began as a vision to elevate industry standards has evolved into a legacy of cleanroom solutions that protect the world’s most critical processes.

5. AES Box ™ Pharmaceutical Modular Cleanroom 9/16/2025

   AES Box™ is a modular architectural system that delivers our best-in-class modular cleanroom design and integrates seamlessly with your current project infrastructure while providing the compliance and quality you need.

6. Manufacturing Interleukin-2 For In Vivo Use: Key Considerations 9/16/2025

   Interleukins help optimize therapeutic outcomes in cancer immunotherapy and regenerative medicine. Manufacturing success requires stringent control over production, formulation, and stability to ensure safety and efficacy.

7. Sanofi's Digitalization Road Trip Shifts Into High Gear 9/16/2025

   The company's head of manufacturing discusses their latest investments in AI and automation, plus offers tips on how any company can start adopting advanced technology.

8. Why Pharmaceutical And Medical Device Risks Must Be Analyzed By Their Risk Mechanisms 9/16/2025

   Current risk analysis methods focus on the possibility and severity of bad events instead of focusing directly on analyzing and improving the performance of systems and processes producing the bad events. 

9. NanoCell's Moonshot Aims To Unlock In Vivo Cell Therapy 9/16/2025

   If the science holds, the implications include substantial cost reduction and putting engineered T cell therapies within reach of patients anywhere in the world.

10. The Regulatory Imperative To Improve Environmental And Sustainability Stewardship In Biopharma 9/15/2025

    As the industry faces increasing pressure to align with environmental, social, and governance (ESG) standards, companies must evaluate how to integrate supply chain management with these initiatives to drive sustainability and mitigate risks.